Chronic Lymphocytic Leukemia Refractory
2 clinical trials · Condition
◉ Watch Chronic Lymphocytic Leukemia Refractory
| Record | Firm | Date |
|---|---|---|
| Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies (NCT05705570) | Nelson Hamerschlak | 2023-02-07 |
| MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) (NCT03853616) | Miltenyi Biomedicine GmbH | 2018-11-26 |
Track Chronic Lymphocytic Leukemia Refractory automatically
Every clearance here is in the API, with alerts when new ones post.